ArticleSaudi journal of biological sciences2020
Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic
Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Iran's Escherichia coli AMR Landscape (2010-2025): A One Health Systematic Review and Meta-Analysis.MicrobiologyOpen · 2026Pooled it
- Genomic diversity of uropathogenic Escherichia coli in clinical isolates from six latin american countries, 2018-2023.Revista peruana de medicina experimental y salud publica · 2025Article
- Pathogenesis and Immunomodulation of Urinary Tract Infections Caused by UropathogenicMicroorganisms · 2025Review
- Avian pathogenicVeterinary world · 2024Review
- Short- and Long-Read Sequencing Reveals the Presence and Evolution of an IncF Plasmid HarboringMicrobiology spectrum · 2023Article
- High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan.World journal of microbiology & biotechnology · 2023Article
- Possible step-up in prevalence for Escherichia coli ST131 from fecal to clinical isolates: inferred virulence potential comparative studies within phylogenetic group B2.Journal of biomedical science · 2022Article
- MALDI-TOF MS for Rapid Analysis of Bacterial Pathogens Causing Urinary Tract Infections in the Riyadh Region.Diseases (Basel, Switzerland) · 2022Article
- A Three-Year Look at the Phylogenetic Profile, Antimicrobial Resistance, and Associated Virulence Genes of UropathogenicPathogens (Basel, Switzerland) · 2022Article
- Comparative Metabolic Characterization of Extraintestinal PathogenicJournal of tropical medicine · 2022Article
- Epidemiological and genomic characteristics of globalFrontiers in microbiology · 2022Article
- Comparative phenotypic characterization identifies few differences in the metabolic capacity betweenSaudi journal of biological sciences · 2021Article
- Comparative Study of CTX-M-15 ProducingInfection and drug resistance · 2021Article
- Epidemic Potential ofInfection and drug resistance · 2021Article
- Vitamin D deficiency as a risk factor for urinary tract infection in women at reproductive age.Saudi journal of biological sciences · 2020Article
- Prevalence ofInternational journal of microbiology · 2020Article
- Prevalence of Virulence Genes and Their Association with Antimicrobial Resistance Among PathogenicInfection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe antimicrobial resistance of extraintestinal pathogenic
methodsSixty
resultsGroup B2 was the most common phylogroup from which
conclusionThis study reported the prevalence and traits of clinical
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.